Efficacy of natalizumab therapy in patients of African descent with relapsing multiple sclerosis: analysis of AFFIRM and SENTINEL data. [electronic resource]
Producer: 20110607Description: 464-8 p. digitalISSN:- 1538-3687
- Adult
- Black or African American -- ethnology
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Drug Therapy, Combination -- methods
- Female
- Humans
- Interferon beta-1a
- Interferon-beta -- administration & dosage
- Male
- Middle Aged
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Natalizumab
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.